1.17.3.2: xanthine oxidase
This is an abbreviated version!
For detailed information about xanthine oxidase, go to the full flat file.
Word Map on EC 1.17.3.2
-
1.17.3.2
-
allopurinol
-
uric
-
dismutase
-
catalase
-
sod
-
xx
-
endothelial
-
malondialdehyde
-
hyperuricemia
-
reperfusion
-
gout
-
ischemia
-
purine
-
artery
-
karyotype
-
turner
-
myocardial
-
gsh
-
pulmonary
-
myeloperoxidase
-
ischemia-reperfusion
-
gonad
-
hermaphrodite
-
oxypurinol
-
thiobarbituric
-
urate
-
spin
-
tbars
-
chemiluminescence
-
dysgenesis
-
molybdenum
-
gsh-px
-
sex-determining
-
caffeine
-
x-chromosome
-
oxygen-derived
-
tungsten
-
acid-reactive
-
masculinization
-
fenton
-
sex-reversed
-
hypouricemic
-
monosomy
-
feminization
-
drug development
-
diagnostics
-
urate-lowering
-
synthesis
-
self-fertilizing
-
biotechnology
-
medicine
-
radical-generating
-
cyp2a6
-
oxidase-derived
-
pharmacology
-
nondisjunction
- 1.17.3.2
- allopurinol
-
uric
- dismutase
- catalase
- sod
- xx
- endothelial
- malondialdehyde
-
hyperuricemia
-
reperfusion
- gout
- ischemia
- purine
- artery
- karyotype
-
turner
- myocardial
- gsh
- pulmonary
- myeloperoxidase
-
ischemia-reperfusion
- gonad
-
hermaphrodite
- oxypurinol
-
thiobarbituric
- urate
-
spin
-
tbars
-
chemiluminescence
- dysgenesis
- molybdenum
- gsh-px
-
sex-determining
- caffeine
-
x-chromosome
-
oxygen-derived
- tungsten
-
acid-reactive
-
masculinization
-
fenton
-
sex-reversed
-
hypouricemic
-
monosomy
-
feminization
- drug development
- diagnostics
-
urate-lowering
- synthesis
-
self-fertilizing
- biotechnology
- medicine
-
radical-generating
- cyp2a6
-
oxidase-derived
- pharmacology
-
nondisjunction
Reaction
Synonyms
AXOR, EC 1.1.3.22, EC 1.2.3.2, EC 1.2.3.2., hypoxanthine oxidase, hypoxanthine-xanthine oxidase, hypoxanthine:oxygen oxidoreductase, More, oxidase, xanthine, Schardinger enzyme, xanthine dehydrogenase/oxidase, xanthine oxidase, xanthine oxidoreductase, xanthine: oxygen oxidoreductase, xanthine:O2 oxidoreductase, xanthine:oxygen oxidoreductase, xanthine:xanthine oxidase, XnOx, XO, XOD, XOR
ECTree
Advanced search results
Engineering
Engineering on EC 1.17.3.2 - xanthine oxidase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
E802Q
-
site-directed mutagenesis, altered kinetics of the mutant enzyme compared to the wild-type enzyme
C1318Y
-
naturally occuring single nucleotide polymorphism, the mutant variant shows reduced activity compared to the wild-type enzyme
E308V
-
site-directed mutagenesis, mutant molybdopterin domain structure, overview, the xanthine oxidase changes its substrate specificity to aldehyde oxidase type upon mutation of amino acid residues in the active site, the E803V mutation almost completely abrogates the activity towards hypoxanthine as a substrate, but the decrease in activity towards purine substrate is not due to large conformational change in the mutant enzyme
H1221R
-
naturally occuring nonsynonymous single nucleotide polymorphism, the mutant variant shows about twofold increased activity compared to the wild-type enzyme
I703V
-
naturally occuring single nucleotide polymorphism, the mutant variant shows abput twofold increased activity compared to the wild-type enzyme
N909K
-
naturally occuring single nucleotide polymorphism, the mutant variant shows reduced activity compared to the wild-type enzyme
P1150R
-
naturally occuring single nucleotide polymorphism, the mutant variant shows reduced activity compared to the wild-type enzyme
P555S
-
naturally occuring single nucleotide polymorphism, the mutant variant shows reduced activity compared to the wild-type enzyme
R607Q
-
naturally occuring single nucleotide polymorphism, the mutant variant shows reduced activity compared to the wild-type enzyme
R881M
-
site-directed mutagenesis, the xanthine oxidase changes its substrate specificity to aldehyde oxidase type upon mutation of amino acid residues in the active site, the R881M mutant lacks activity towards xanthine, but retaines slight activity towards hypoxanthine
T623I
-
naturally occuring single nucleotide polymorphism, the mutant variant shows reduced activity compared to the wild-type enzyme
C535A/C992R
site-directed mutagenesis, the mutant activity in the presence of sulfhydryl residue modifiers is very low
C535A/C992R/C1316S
site-directed mutagenesis, the triple mutant does not undergo conversion from XOR, EC 1.17.3.2, to XDH, EC 1.17.1.4, at all
C535A/C992R/C1324S
site-directed mutagenesis, the triple mutant does not undergo conversion from XOR, EC 1.17.3.2, to XDH, EC 1.17.1.4, at all
W335A/F336L
E232A
site-directed mutagenesis, the mutant exhibits a 12fold decrease in kred compared to wild-type
E232Q
site-directed mutagenesis, kred, the limiting rate constant for reduction at high [xanthine], is significantly compromised in the mutant variant E232Q, the mutant exhibits a 12fold decrease in kred, a result that is inconsistent with Glu232 being neutral in the active site of the wild-type enzyme
additional information
xanthine oxidoreductase mutant displaying xanthine oxidase activity
additional information
construction of a variant of the rat liver enzyme that lacks the C-terminal amino acids 1316-1331. The mutant enzymes appears to assume an intermediate form, exhibiting a mixture of dehydrogenase and oxidase activities. The purified mutant protein retains about 50-70% of oxidase activity even after prolonged dithiothreitol treatment. The C-terminal region plays a role in the dehydrogenase to oxidase conversion. In the crystal structure of the protein variant, most of the enzyme stays in an oxidase conformation. But after 15 min of incubation with a high concentration of NADH, the corresponding X-ray structures show a dehydrogenase-type conformation. On the other hand, disulfide formation between Cys535 and Cys992, which can clearly be seen in the electron density map of the crystal structure of the mutant after removal of dithiothreitol, goes in parallel with the complete conversion to oxidase, resulting in structural changes identical to those observed upon proteolytic cleavage of the linker peptide